,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['inspire', 'breast', 'destinybreast04']
check out our manuscript in looking at patients with #hrlow #breastcancer. inspired by the #destinybreast04 data presented at #asco2022. it's time to re-think how we categorize these breast cancer subtypes. #hrlow #her2low 
Heme/Onc Fellow @uw_hemeoncpc | Class of 2021 @uw_IMresidency I Class of 2018 @rushumedcollege | Class of 2013 @UMich | #WomeninMedicine. Views are my own.